World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01205191
Date of registration: 16/09/2010
Primary sponsor: Linkoeping University
Public title: Cell Phone-supported Cognitive Behavioural Therapy LINNEA
Scientific title: Effectiveness Study of Cell Phone-supported Cognitive Behavioural Therapy for Anxiety Disorders in Frontline Settings
Date of first enrolment: April 2011
Target sample size: 400
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01205191
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research  
Countries of recruitment
Sweden
Contacts
Name:   Karin Halje, MSc
Address: 
Telephone: +46 10 103 0000
Email: karin.halje.lindgren@lio.se
Affiliation: 
Name:   Toomas Timpka, MD PhD
Address: 
Telephone:
Email:
Affiliation:  Section of Social Medicine/LiU
Key inclusion & exclusion criteria

Inclusion Criteria:

- age 18 to 25; and

- scoring 7 or higher on the anxiety section of the Hospital Anxiety and Depression
scale (HADS) at initial evaluation.

Exclusion Criteria:

- at the initial evaluation displays symptoms indicative for referral to a psychiatric
specialist, e.g. active suicidal ideas or symptoms of a psychotic disorder, organic
mental disorder or alcohol and/or drug dependence; or

- is unable to read, write or speak in the Swedish;



Age minimum: 18 Years
Age maximum: 25 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Anxiety
Intervention(s)
Behavioral: CBT
Behavioral: CBT with digital audio player support
Behavioral: Cell-phone supported CBT
Primary Outcome(s)
Anxiety [Time Frame: Six months after treatment]
Secondary Outcome(s)
Adherence [Time Frame: 14 weeks]
Secondary ID(s)
LFP5/08
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history